Polomar Health Services, Inc. (PMHS)

Market Cap	10.79M
Revenue	n/a
Net Income	n/a
Shares Out	27.66M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	139
Open	0.3900
Previous Close	0.3900
Day's Range	0.3900 - 0.3900
52-Week Range	0.0703 - 1.5000
Beta	n/a
RSI	51.86
Earnings Date	n/a

About Polomar Health Services

Polomar Health Services, Inc. operates as a compounding pharmacy that offers customized medications, generic drugs, and rapid prescription processing. The company offers Tofacitinib that treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and Sildenafil (Generic Viagra) that improves blood to treat erectile dysfunction and pulmonary hypertension. It also offers skincare products. The company was founded in 2023 and is based in...

• Industry: Internet Content & Information
• Sector: Communication Services
• Founded: 2023
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMHS